MOUNJARO WEIGHT LOOS - AN OVERVIEW

The addition of Wegovy® in individuals treated with insulin has not been evaluated. When initiating Wegovy®, consider lessening the dose of concomitantly administered insulin secretagogues (for example sulfonylureas) or insulin to lessen the risk of hypoglycemia2)]. Anaphylaxis and angioedema happen to be described with GLP-one receptor agonists.